AL

Ascension Life Fund

Europe, England, United Kingdom, London

Description

Ascension Life Fund invests into a portfolio of at least 8 high potential HealthTech and Life Science companies per year.

Investor Profile

Ascension Life Fund has made 5 investments, with 1 in the past 12 months and 20% as lead.

Stage Focus

  • Seed (60%)
  • Series A (20%)
  • Series Unknown (20%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Medical
  • Medical Device
  • Biotechnology
  • Analytics
  • Health Care
  • Machine Learning
  • Life Science
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ascension Life Fund frequently co-invest with?

HH
Europe, England, United Kingdom, London
Co-Investments: 1
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 1
QantX
Europe, Devon, United Kingdom, Exeter
Co-Investments: 1
FW
Europe, England, United Kingdom, London
Co-Investments: 1
Playfair Capital
Europe, England, United Kingdom, London
Co-Investments: 1
C&
Europe, Cornwall, United Kingdom, Truro
Co-Investments: 1
Guinness Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
MA
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
XTX Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Empirical Ventures
Europe, Bristol, City of, United Kingdom, Bristol
Co-Investments: 1

What are some of recent deals done by Ascension Life Fund?

Qureight

Cambridge, Cambridgeshire, United Kingdom

Qureight is an imaging analytics company.

AnalyticsHealth CareMachine Learning
Series AApr 15, 2024
Amount Raised: $8,463,427
Neuronostics

Bristol, Bristol, City of, United Kingdom

Neuronostics develop clinical decision support systems and at-home monitoring tools for neurological conditions

MedicalMedical Device
SeedApr 5, 2024
Amount Raised: $2,654,189
NunaBio

Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom

NunaBio operates as a privately-owned specialist DNA development company.

BiotechnologyLife ScienceMedicalProduct Research
SeedApr 20, 2023
Amount Raised: $2,363,760
Nebu~Flow

Glasgow, Glasgow City, United Kingdom

Nebu~Flow developing the next generation of nebulizers to enable the delivery of life-changing treatments.

Medical Device
SeedMay 10, 2022
Amount Raised: $2,092,019
Amlo Biosciences

Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom

AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.

Biotechnology
Series UnknownApr 21, 2022
Amount Raised: $3,191,031